Stewart Jeffrey Ryan
SEC CIK 1761675 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | EVP, Chief Commercial Off | 83.2K | — | $38.86M | 21 | 2021-12-10 | 2026-02-27 |
Most active insiders at ABBV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Siatis Perry C | EVP, GC AND Sec | — | $9.52M |
| 2 | Donoghoe Nicholas | EVP, CHIEF BUS, STRAT Off | — | $8.18M |
| 3 | Purdue David Ryan | SVP, Ctrl | — | $1.22M |
| 4 | Crum Demetris D | EVP, Chief HR Off | — | — |
| 5 | Thakkar Roopal | EVP, CSO, R, D | — | — |
| 6 | Quaggin Susan E | Dir | — | — |
| 7 | Reents Scott T | EVP, CFO | — | — |
| 8 | Davis Jennifer L. | Dir | — | — |
| 9 | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | — | — |
| 10 | MEYER MELODY B | Dir | — | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-02-27 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | F - Tax | $232.08 | -23.8K | 83.2K | -22% | -$5.53M | |
| DM | 2026-02-20 | 2026-02-18 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | A - Grant | $0.00 | +53.7K | 79.3K | +210% | $0 |
| D | 2025-04-02 | 2025-03-31 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | M - OptEx | $79.02 | +25.7K | 112.1K | +30% | +$2.03M |
| DM | 2025-04-02 | 2025-03-31 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | S - Sale+OE | $210.08 | -58.8K | 86.4K | -41% | -$12.36M |
| 2025-03-04 | 2025-02-28 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | F - Tax | $205.02 | -20.2K | 86.4K | -19% | -$4.15M | |
| DM | 2025-02-18 | 2025-02-13 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | A - Grant | $0.00 | +45.7K | 97.2K | +89% | $0 |
| D | 2024-03-20 | 2024-03-18 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | M - OptEx | $61.36 | +26.1K | 119.9K | +28% | +$1.60M |
| DM | 2024-03-20 | 2024-03-18 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | S - Sale+OE | $178.79 | -58.9K | 88.7K | -40% | -$10.54M |
| 2024-03-01 | 2024-02-28 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | F - Tax | $178.99 | -26.1K | 93.8K | -22% | -$4.68M | |
| DM | 2024-02-20 | 2024-02-15 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | A - Grant | $0.00 | +59.0K | 119.9K | +97% | $0 |
| DM | 2023-03-15 | 2023-03-13 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | S - Sale+OE | $152.28 | -53.1K | 60.9K | -47% | -$8.09M |
| D | 2023-03-15 | 2023-03-13 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | M - OptEx | $54.86 | +21.8K | 114.1K | +24% | +$1.20M |
| 2023-03-02 | 2023-02-28 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, COMMERCIAL Ops | F - Tax | $154.28 | -24.9K | 92.3K | -21% | -$3.84M | |
| DM | 2023-02-21 | 2023-02-16 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, COMMERCIAL Ops | A - Grant | $0.00 | +56.2K | 117.2K | +92% | $0 |
| D | 2022-03-25 | 2022-03-24 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief Commercial Off | M - OptEx | $58.88 | +27.7K | 88.6K | +45% | +$1.63M |
| D | 2022-03-25 | 2022-03-24 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief Commercial Off | S - Sale+OE | $159.20 | -27.7K | 60.9K | -31% | -$4.41M |
| 2022-03-01 | 2022-02-25 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief Commercial Off | F - Tax | $149.54 | -17.1K | 82.4K | -17% | -$2.56M | |
| M | 2022-03-01 | 2022-03-01 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief Commercial Off | S - Sale | $148.25 | -21.5K | 63.5K | -25% | -$3.19M |
| DM | 2022-02-22 | 2022-02-17 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief Commercial Off | A - Grant | $0.00 | +52.4K | 70.5K | +290% | $0 |
| 2021-12-17 | 2021-12-15 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief Commercial Off | S - Sale | $128.00 | -2,152 | 47.1K | -4% | -$275.5K | |
| 2021-12-14 | 2021-12-10 | ABBV | AbbVie | Stewart Jeffrey Ryan | EVP, Chief Commercial Off | F - Tax | $124.15 | -1,713 | 49.3K | -3% | -$212.7K |
Purchase Sale Sale after option exercise All abbreviations